Sabra Health Care REIT (SBRA) Misses Q1 FFO by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Qualcomm (QCOM) Reports In-Line Q4 EPS, Beats on Revenue; Offers Q1 Guidance
- Intel shares fall as competitor reports record results
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- SanDisk shares fall on election and chip sector pressure
- After-Hours Movers: QCOM, COHR, APP, HUBS, SNAP, FSLY, FIG, ZG, BROS, CDE
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
Sabra Reports First Quarter 2016 Results; Reports Normalized FFO and AFFO Per Share of $0.56 and $0.53, Respectively, Representing an Increase of 6% and 2%, Respectively, Over First Quarter 2015; Incr
May 2, 2016 4:05 PM EDTIRVINE, Calif, May 02, 2016 (GLOBE NEWSWIRE) -- Sabra Health Care REIT, Inc. (Sabra, the Company or we) (NASDAQ: SBRA) (Nasdaq: SBRAP) today announced results of operations for the first quarter of 2016.
RECENT HIGHLIGHTSÂ
For the first quarter of 2016, Normalized FFO, AFFO and net (loss) income attributable to common stockholders per diluted common share were $0.56, $0.53 and $(0.28), respectively, compared to $0.53, $0.52 (normalized) and $0.28, respectively, for the first quarter of 2015. During the three months ended March 31, 2016, we incurred a $29.8 million impairment on real estate related to Forest Park Medical... More


